MorphoSys and Incyte announce the acceptance of the Swissmedic marketing authorisation application for tafasitamab

5 January 2021 - The Swissmedic marketing authorisation application seeks approval for tafasitamab in combination with lenalidomide for the treatment ...

Read more →

Swissmedic approves Buvidal for the treatment of opioid dependence

18 December 2020 - Camurus announced today that the Swiss agency for therapeutic products, Swissmedic, has approved weekly and monthly Buvidal ...

Read more →

Swiss to start Pfizer COVID-19 vaccine jabs after watchdog's OK

19 December 2020 - Switzerland will start getting doses of COVID-19 vaccine from Pfizer and partner BioNTech within days after ...

Read more →

Switzerland ramps up COVID-19 vaccine order

9 December 2020 - Switzerland has increased its coronavirus vaccine order with Moderna by three million doses.  ...

Read more →

Switzerland secures three million doses of Pfizer/BioNTech vaccine

7 December 2020 - Switzerland has signed an agreement with a third manufacturer of COVID-19 vaccines for three million doses.  ...

Read more →

Incomplete data stalls Swiss authorisation of COVID-19 vaccines

3 December 2020 - Switzerland’s medical regulator Swissmedic says it lacks the necessary information to sign off on three different coronavirus ...

Read more →

Swissmedic begins rolling review of Moderna’s mRNA vaccine against COVID-19 (mRNA-1273)

13 November 2020 - Moderna completed enrolment of its Phase 3 COVE study of mRNA-1273 on October 22. ...

Read more →

Swissmedic fast-tracks second anti-viral vaccine

19 October 2020 - Swissmedic said the United States pharmaceutical company Pfizer submitted an application for the authorisation of a ...

Read more →

Swissmedic reviewing AstraZeneca’s COVID-19 vaccine

6 October 2020 - Swiss drug authority Swissmedic has begun evaluating the so-called “Covid-19 Vaccine AstraZeneca”.  ...

Read more →

Swissmedic approval times slow down

20 August 2020 - Swissmedic took 4% longer to process each new application for a new active substance (NA NAS) ...

Read more →

Swiss data protection chief pushes back on drug pricing secrecy

20 August 2020 - A proposed change to the new health insurance law that seeks to keep drug prices under lock ...

Read more →

Drug prices fall in Switzerland but generics remain expensive

13 August 2020 - Switzerland is narrowing the gap with other European countries when it comes to the cost of medicines. ...

Read more →

PharmaMar has filed lurbinectedin for Temporary Marketing Authorisation with the Swiss Agency for Therapeutic Products

20 July 2020 - The filing is based on the Phase II multi-centre basket trial efficacy data. ...

Read more →

Switzerland fast-tracks anti-viral medication against COVID-19

2 July 2020 - Swissmedic, the agency that oversees the use of medicaments in Switzerland, took days to fast-track approval ...

Read more →

Swissmedic approves Carbetocin Ferring for the prevention of postpartum haemorrhage in all births

13 May 2020 - Carbetocin Ferring is the first medicine approved under the new Swissmedic and Marketing Authorisation for Global Health ...

Read more →